Evidence map›Paper›PMID 37344587›Full record

ArticleNature2023

Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor.

Luke A Greenhough, Chih-Chao Liang, Ondrej Belan, Simone Kunzelmann, Sarah Maslen, Monica C Rodrigo-Brenni, Roopesh Anand, Mark Skehel, Simon J Boulton, Stephen C West

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Mechanisms That Govern Recombinase Fidelity Control During Eukaryotic Homologous Recombination.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Impact of germlineMolecular therapy. Oncology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. High-throughput mapping of 6,888bioRxiv : the preprint server for biology · 2026
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Luke A Greenhough *The Francis Crick Institute, London, UK.
Chih-Chao Liang *The Francis Crick Institute, London, UK.
Ondrej Belan *The Francis Crick Institute, London, UK.
Simone KunzelmannThe Francis Crick Institute, London, UK.ORCID 0000-0002-2678-0549
Sarah MaslenThe Francis Crick Institute, London, UK.
Monica C Rodrigo-BrenniThe Francis Crick Institute, London, UK.
Roopesh AnandThe Francis Crick Institute, London, UK.ORCID 0000-0001-9461-6655
Mark SkehelThe Francis Crick Institute, London, UK.
Simon J BoultonThe Francis Crick Institute, London, UK.ORCID 0000-0001-6936-6834
Stephen C WestThe Francis Crick Institute, London, UK. stephen.west@crick.ac.uk.ORCID 0000-0001-8848-9418
The Francis Crick Institute · GBAstraZeneca (United Kingdom) · GBBrigham and Women's Hospital · US

Funding

Cancer Research UK CC2098Wellcome Trust 206292/Z/17/ZWellcome Trust CC2057Wellcome Trust CC2098
6 · The paper itself

Abstract

Homologous recombination is a fundamental process of life. It is required for the protection and restart of broken replication forks, the repair of chromosome breaks and the exchange of genetic material during meiosis. Individuals with mutations in key recombination genes, such as BRCA2 (also known as FANCD1), or the RAD51 paralogues RAD51B, RAD51C (also known as FANCO), RAD51D, XRCC2 (also known as FANCU) and XRCC3, are predisposed to breast, ovarian and prostate cancers

Indexed as

Cryoelectron MicroscopyDNA-Binding ProteinsMultiprotein ComplexesRad51 RecombinaseTumor Suppressor ProteinsComputer SimulationDNA Breaks, Double-StrandedDNA RepairDNA ReplicationHomologous RecombinationHumansNeoplasmsPoly(ADP-ribose) Polymerase InhibitorsProteomicsDNA-Binding ProteinsMultiprotein ComplexesPoly(ADP-ribose) Polymerase InhibitorsRAD51B protein, humanRAD51C protein, humanRAD51D protein, humanRad51 RecombinaseTumor Suppressor ProteinsXRCC2 protein, human

Identifiers

PMID37344587
PMCPMC7614784
OpenAlexW4381489574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.